Earnings roundup: AbbVie angst, a bifurcated vaccine market and Bristol Myers’ waiting game
With quarterly earnings underway, BioPharma Dive is providing a snapshot of some companies’ results and how they’re being received by investors. Today, we’re offering insight into the latest numbers from Bristol Myers Squibb, GSK and AbbVie. AbbVie angst …